MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least 3 prior medical oncology visits.

Disqualifiers

Patient is enrolled on a therapeutic clinical trial.

Patients whose primary language is not currently supported by Epic.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Usual practice pattern (UPP)

    Other intervention

    Patient follows usual practice pattern for routine care

  • Experimental: Enhanced Telehealth (ET)

    Other intervention

    Patient follows enhanced telehealth practice pattern. As clinically appropriate, patients given option to shift routine care from face-to-face to at-home services available at institution: telehealth visits, home phlebotomy, and educational support for home administration of injection medications

Treatment groups

1,750 Participants
are divided into 2 treatment groups
Group A: Usual practice pattern (UPP)Active comparator 2 interventions
Group B: Enhanced Telehealth (ET)Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Proportion of routine face to face medical oncology related visits out of total medical oncology related visits

all patients who meet eligibility criteria and have completed at least 2 medical oncology visits during the 12 month follow up period will be included for endpoint evaluability during analyses

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.